Endovascular femoropopliteal bypass

Annals of Vascular Surgery

Volumn 14, Issue 3, 2000, Pages 291-295

  Morris, Gareth E ^a  

^a UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ENDOVASCULAR SURGERY; FEMOROPOPLITEAL BYPASS; HUMAN; INTERMETHOD COMPARISON; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; POLITEF IMPLANT; PRIORITY JOURNAL;

EID: 0034017675     PISSN: 08905096     EISSN: None     Source Type: Journal    
DOI: 10.1007/s100169910051     Document Type: Article

References (51)

1. Imparato AM, Kim GE, Davidson T, Crowley JG. Intermittent claudication: its natural course. Surgery 1975;78:795-799.
2. Tilanus HW, Obertop H, Van Urk H. Saphenous vein or PTFE for femoropopliteal bypass. A prospective randomized trial. Ann Surg 1985;202:780-782.
3. Veith FJ, Gupta SK, Ascer E, et al. Six-year prospective multicenter randomized comparison of autologous saphenous vein and expanded polytetralluoroethylene grafts in infrainguinal arterial reconstructions. J Vasc Surg 1986;3:104-114.
4. Buchbinder D, Lloyd WE, Shah DM, Rollins DL, Semrow C, Leather RP. The in situ bypass above the knee. Ann Vasc Surg 1989;3:210-213.
5. Taylor LM Jr, Edwards JM, Porter JM. Present status of reversed vein bypass grafting: five-year results of a modern series. J Vasc Surg 1990;11:193-205.
6. Charlesworth PM, Brewster DC, Darling RC, Robison JG, Hallet JW. The fate of polytetrafluoroethylene grafts in lower limb bypass surgery: a six year follow-up. Br J Surg 1985;72:896-899.
7. Quiñones-Baldrich WJ, Busuttil RW, Baker JD, et al. Is the preferential use of polytetrafluoroethylene grafts for femoropopliteal bypass justified? J Vasc Surg 1988;8:219-228.
8. Prendiville EJ, Yeager A, O'Donnell TJ, et al. Long-term results with the above-knee popliteal expanded polytetrafluoroethylene graft. J Vasc Surg 1990;11:517-524.
9. Rosenthal D, Evans RD, McKinsey J, et al. Prosthetic above-knee femoropopliteal bypass for intermittent claudication. J Cardiovasc Surg Torino 1990;31:462-468.
10. Woratyla SP, Darling RC, 3rd, Chang BB, et al. The performance of femoropopliteal bypasses using polytetrafluoroethylene above the knee versus autogenous vein below the knee. Am J Surg 1997;174:169-172.
11. Arlart IP, Gerlach A, Grass HG. Laser-assisted balloon angioplasty in complete femoropopliteal occlusions: preliminary results. Cardiovasc Intervent Radiol 1991;14:233-237.
12. Lammer J, Pilger E, Karnel F, et al. Laser angioplasty: results of a prospective, multicenter study at 3-year follow-up. Radiology 1991;178:335-337.
13. Johnston KW. Femoral and popliteal arteries: reanalysis of results of balloon angioplasty. Radiology 1992;183:767-771.
14. Sapoval MR, Long AL, Raynaud AC, Beyssen BM, Fiessinger JN, Gaux JC. Femoropopliteal stent placement: long-term results. Radiology 1992;184:833-839.
15. Martin EC, Katzen BT, Benenati JF, et al. Multicenter trial of the wallstent in the iliac and femoral arteries. J Vasc Interv Radiol 1995;6:843-849.
16. Ahn SS, Concepcion B. Indications and results of arterial stems for occlusive disease. World J Surg 1996;20:644-648.
17. Damaraju S, Cuasay L, Le D, Strickman N, Krajcer Z. Predictors of primary patency failure in Wallstent self-expanding endovascular prostheses for iliofemoral occlusive disease. Tex Heart Inst J 1997;24:173-178.
18. Bergeron P, Pinot JJ, Poyen V, et al. Long-term results with the Palmaz stent in the superficial femoral artery. J Endovasc Surg 1995;2:161-167.
19. Henry M. Amor M, Ethevenot G, et al. Palmaz stent placement in iliac and femoropopliteal arteries: primary and secondary patency in 310 patients with 2-4-year follow-up. Radiology 1995;197:167-174.
20. Henry M, Amor M, Beyar R, et al. Clinical experience with a new nitinol self-expanding stent in peripheral arteries. J Endovasc Surg 1996;3:369-379.
21. Dorros G, Iyer S, Lewin R, Zaitoun R, Mathiak L, Olson K. Angiographic follow-up and clinical outcome of 126 patients after percutaneous directional atherectomy (Simpson AtheroCath) for occlusive peripheral vascular disease. Cathet Cardiovasc Diagn 1991;22:79-84.
22. Vroegindeweij D, Kemper FJ, Tielbeek AV, Buth J, Landman G. Recurrence of stenoses following balloon angioplasty and Simpson atherectomy of the femoro-popliteal segment. A randomised comparative 1-year follow-up study using colour flow duplex. Eur J Vasc Surg 1992;6:164-171.
23. The Collaborative Rotablator Atherectomy Group. Peripheral atherectomy with the rotablator: a multicenter report. J Vasc Surg 1994;19:509-515.
24. London NJ, Srinivasan R, Naylor AR, et al. Subintimal angioplasty of femoropopliteal artery occlusions: the long-term results. Eur J Vasc Surg 1994;8:148-155.
25. Marin ML, Veith FJ. Endovascular stented grafts in the treatment of aortoiliac and femoropopliteal occlusive disease. Presented at the 21st Annual Symposium: Current Critical Problems in Vascular Surgery, 1994, New York.
26. Keynton RS, Rittgers SE, Shu MC. The effect of angle and flow rate upon hemodynamics in distal vascular graft anastomoses: an in vitro model study. J Biomich Eng 1991;113: 458-463.
27. Bassiouny HS, White S, Glagov S, Choi E, Giddens DP, Zarins CK. Anastomotic intimal hyperplasia: mechanical injury or flow induced. J Vasc Surg 1992;15:708-716.
28. Marin ML, Veith FJ, Cynamon J, et al. Human transluminally placed endovascular stented grafts: preliminary histopathologic analysis of healing grafts in aortoiliac and femoral artery occlusive disease. J Vasc Surg 1995;21:595-603.
29. Ohki T, Marin ML, Veith FJ, et al. Anastomotic intimal hyperplasia: a comparison between conventional and endovascular stem graft techniques. J Surg Res 1997;69:255-267.
30. Hoedt MTC, van der Lugt A, van Urk H, Wittens CHA. Long term follow-up of femoropopliteal bypasses comparing patencies and complications related to distal end-to-side and end-to-end anastomoses. Presented at the European Society for Vascular Surgery XII Annual Meeting, 1998, Paris.
31. van Urk H. The "ideal" end-to-end anastomosis of an endovascular femoropopliteal bypass: an IVUS study. J Endovasc Surg 1998;5(Suppl 1):34.
32. Cragg AH, Dake MD. Percutaneous femoropopliteal graft placement. Radiology 1993;187:643-648.
33. Henry M, Amor M, Ethevenot G, et al. Initial experience with the Cragg Endopro System 1 for intraluminal treatment of peripheral vascular disease. J Endovasc Surg 1994;1:31-43.
34. Henry M, Amor M, Henry I, Porte JM, Tzvetanov K, Mentre B. Initial experience with the Corvita endoluminal graft in peripheral arteries. J Endovasc Surg 1997;4(Suppl 1):14-15.
35. Diethrich EB, Papazoglou K. Endoluminal grafting for aneurysmal and occlusive disease in the superficial femoral artery: early experience. J Endovasc Surg 1995;2:225-239.
36. Spoelstra H, Casselman F, Lesceu O. Balloon-expandable endobypass for femoropopliteal atherosclerotic occlusive disease. A preliminary evaluation of fifty-five patients. J Vasc Surg 1996;24:647-654.
37. Bergeron P. Stenting and endoluminal grafting of femoral and popliteal arteries [Abstract]. Endovasc Surg 1995;2:197-198.
38. Ho GH, Moll FL, Tutein Nolthenius RP, van den Berg JC, Overtoom TTC. Endovascular femoropopliteal bypass combined with remote endarterectomy in SFA occlusive disease: initial experience. Eur J Vasc Endovasc Surg 2000;19:35-42.
39. Ho GH, Moll FL, Joosten PP, van de Pavoordt ED, Overtoom TT. The Mollring Cutter remote endarterectomy: preliminary experience with a new endovascular technique for treatment of occlusive superficial femoral artery disease. J Endovasc Surg 1995;2:278-287.
40. Ho GH, Moll FL, Hedeman Joosten PP, van de Pavoordt HD, van den Berg JC, Overtoom TT. Endovascular remote end-arterectomy in femoropopliteal occlusive disease: one-year clinical experience with the ring strip cutter device. Eur J Vasc Endovasc Surg 1996;12:105-112.
41. Ho GH, Moll FL. Remote endarterectomy in SFA occlusive disease. Eur J Radiol 1998;28:205-210.
42. Ho GH, van Buren PA, Moll FL, van der Bom JG, Eikelboom BC. Incidence, time-of-onset, and anatomical distribution of recurrent stenoses after remote endarterectomy in superficial femoral artery occlusive disease. J Vasc Surg 1999;30: 106-113.
43. Morris GE, Ahn SS, Quick CR, Kaiura TL, Reger VA. Endovascular femoropopliteal bypass: a cadaveric study. Eur J Vasc Endovasc Surg 1995;10:9-15.
44. Ahn SS, Reger VA, Kaiura TL. Endovascular femoropopliteal bypass: early human cadaver and animal studies. Ann Vasc Surg 1995;9:28-36.
45. Cragg AH, Dake MD. Treatment of peripheral vascular disease with stem-grafts. Radiology 1997;205:307-314.
46. Stockx L. Stent-grafts in the superficial femoral artery. Eur J Radiol 1998;28:182-188.
47. Maynar M, Reyes R, Ferral H, et al. Cragg Endopro System I: early experience. I. Femoral arteries. J Vasc Interv Radiol 1997;8:203-207.
48. van Urk H, van Sambeek MRHM. First experience with the ENDURING vascular graft: an all-PTFE graft that functions as a stem. J Endovasc Surg 1997;4(Suppl 1):43.
49. Bleyn J, Schol F, Vanhandenhove I. Femoropopliteal endobypass using the Hemobahn for occlusive disease: results and lessons learned [Abstract]. J Endovasc Surg 1999;6:80.
50. Bergeron P, Chiarandini S, Nava G, Roth O. Femoral artery endoluminal bypass grafting: indications and early results. J Endovasc Surg 1997;4:404-405.
51. Cowan AR, Morris GE. Mechanical superficial femoral artery endarterectomy and endoluminal femoropopliteal bypass grafting. J Endovasc Surg 1997;4(Suppl 1):7.